Page last updated: 2024-09-03

t 588 and Cranial Nerve VII Injuries

t 588 has been researched along with Cranial Nerve VII Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, K; Iwasaki, Y; Kawazoe, Y; Kinoshita, M; Marubuchi, S; Nakagawa, M; Ono, S; Sakamoto, T; Terashima, N; Watabe, K1
Hayashi, Y; Kawazoe, Y; Watabe, K1

Other Studies

2 other study(ies) available for t 588 and Cranial Nerve VII Injuries

ArticleYear
Oral administration of a neuroprotective compound T-588 prevents motoneuron degeneration after facial nerve avulsion in adult rats.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2003, Volume: 4, Issue:2

    Topics: Administration, Oral; Age Factors; Animals; Body Weight; Cell Survival; Choline O-Acetyltransferase; Diethylamines; Facial Nerve Injuries; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lectins; Male; Motor Neuron Disease; Motor Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; Thiophenes

2003
Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2005, Volume: 25, Issue:4

    Topics: Adenoviridae; Animals; Brain-Derived Neurotrophic Factor; Diethylamines; Disease Models, Animal; Facial Nerve Injuries; Gene Transfer Techniques; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Male; Metallothionein 3; Motor Neuron Disease; Motor Neurons; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Peripheral Nerve Injuries; Peripheral Nerves; Rats; Thiophenes; Transforming Growth Factor beta

2005